Petmed Story

<div class='circular--portrait' style='background:#4E8BFC;color: #ffffff;font-size:4em;'>PE</div>
PETS -- USA Stock  

USD 33.78  1.78  5.56%

My story will sum up PetMed Express. We will evaluate why recent PetMed Express price moves suggest a bounce in February. PetMed Express is at this time traded for 31.63. The entity has historical hype elasticity of 0.38. The average price elasticity to hype of competition is about -0.08. The firm is projected to increase in value after the next press release, with the price going to jump to 1.44. The latest volatility of headline impact on the company stock price is is way over 100 percent making price predictions on social media along less reliable. The price gain on the next news is estimated to be 37.14%, whereas the daily expected return is at this time at -1.3%. Given the investment horizon of 30 days the next projected announcement will be in about 5 days.
Published over a month ago
View all stories for Petmed Express | View All Stories
Will PetMed Express (NASDAQ:PETS) price continue slumping?
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. PetMed Express has an asset utilization ratio of 338.77 percent. This connotes that the company is making $3.39 for each dollar of assets. An increasing asset utilization means that PetMed Express is more efficient with each dollar of assets it utilizes for everyday operations.
The successful prediction of Petmed Express stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Petmed Express, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Petmed Express based on Petmed Express hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Petmed Express's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Petmed Express's related companies.

Use Technical Analysis to project Petmed expected Price

Petmed Express technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Petmed Express technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Petmed Express trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

How Petmed utilizes its cash?

To perform a cash flow analysis of Petmed Express, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Petmed Express is receiving and how much cash it distributes out in a given period. The Petmed Express cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Petmed Express Net Cash Flow from Operations is relatively stable at the moment as compared to the past year. Petmed Express reported last year Net Cash Flow from Operations of 34.96 Million

Detailed Perspective On Petmed Express

The big decline in price over the last few months for PetMed Expressmay encourage retail investors to take a closer look at the company as it is trading at a share price of 31.63 on 142,446 in trading volume. The company executives failed to add value to investors and positioning the company supply of money to exploit market volatility in December. However, diversifying your holdings with PetMed Express or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 30 days investing horizon is currently 12.57. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the PetMed Express partners.

Cost of Revenue Breakdown

PetMed Express Cost of Revenue yearly trend continues to be relatively stable with very little volatility. Cost of Revenue is likely to drop to about 206.7 M. Cost of Revenue usually refers to the aggregate cost of goods produced and sold and services rendered during the reporting period. PetMed Express Cost of Revenue is relatively stable at the moment as compared to the past year. PetMed Express reported last year Cost of Revenue of 216.32 Million
2013155.77 Million
2014153.12 Million
2015158.39 Million
2016169.86 Million
2017175.99 Million
2018188.1 Million
2020216.32 Million
2021206.72 Million

Are PetMed Express technical ratios showing a throwback?

Latest Risk Adjusted Performance is up to -0.1. Price may fall again. PetMed Express is displaying above-average volatility over the selected time horizon. Investors should scrutinize PetMed Express independently to ensure intended market timing strategies are aligned with expectations about PetMed Express volatility.

Our Conclusion on PetMed Express

While some firms in the pharmaceutical retailers industry are either recovering or due for a correction, PetMed may not be as strong as the others in terms of longer-term growth potentials. With a somewhat neutral outlook on your 30 days horizon, it may be better to hold off any trading activity and neither take over new shares of PetMed nor trade your existing holdings in the Stock. It seems the expected volatility has not yet been fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to PetMed Express.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Petmed Express. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to